­
  • Listen Live NOW!
  • On Demand
  • Ways to Listen
  • All Shows
    • Radio Shows
      • Digital Health Talks
      • Health Stealth Radio
      • Health UnaBASHEd
      • Healthcare De Jure
      • Healthcare IT Today
      • News You Can Use
      • PopHealth Week
      • Talking the Walk
      • The Scope with Dr. K
      • The Tate Chronicles
      • The Virtual Shift
      • This Just In Radio Show
      • Trending NOW
      • Value-Based Care Insights
      • What’s My Tagline?
    • Podcast Shows
      • Ambulatory Healthcare Today
      • Ask the Educator
      • FINN Voices
      • Healthcare for Humans
      • Healthcare Rap
      • HealthLaw HotSpot
      • Leader to Leader
      • The MRO Exchange
      • PayerTalkCE
      • Revenue Cycle Optimized
      • Selling to Healthcare
      • The Brain Trust
      • The Handoff
      • Unscripted The AMCP Podcast
    • Monthly/Limited Series Podcasts
      • Follow the Medical Record
      • Informonster Podcast
      • Life-Centered Health Care
      • Take a Listen
      • Tell Me Where IT Hurts
      • The Dish on Health IT
      • Voices of Self Funding
  • Playlists
  • NursesNOW
    • Nursing News
      • Organizations
      • Podcasts
  • Conferences
  • Request a Media Kit
Event Calendar
HealthcareNOWradio.comHealthcareNOWradio.com
  • Listen Live NOW!
  • On Demand
  • Ways to Listen
  • All Shows
    • Radio Shows
      • Digital Health Talks
      • Health Stealth Radio
      • Health UnaBASHEd
      • Healthcare De Jure
      • Healthcare IT Today
      • News You Can Use
      • PopHealth Week
      • Talking the Walk
      • The Scope with Dr. K
      • The Tate Chronicles
      • The Virtual Shift
      • This Just In Radio Show
      • Trending NOW
      • Value-Based Care Insights
      • What’s My Tagline?
    • Podcast Shows
      • Ambulatory Healthcare Today
      • Ask the Educator
      • FINN Voices
      • Healthcare for Humans
      • Healthcare Rap
      • HealthLaw HotSpot
      • Leader to Leader
      • The MRO Exchange
      • PayerTalkCE
      • Revenue Cycle Optimized
      • Selling to Healthcare
      • The Brain Trust
      • The Handoff
      • Unscripted The AMCP Podcast
    • Monthly/Limited Series Podcasts
      • Follow the Medical Record
      • Informonster Podcast
      • Life-Centered Health Care
      • Take a Listen
      • Tell Me Where IT Hurts
      • The Dish on Health IT
      • Voices of Self Funding
  • Playlists
  • NursesNOW
    • Nursing News
      • Organizations
      • Podcasts
  • Conferences
  • Request a Media Kit

    The Myth of Value-Based Pricing for Cancer Drugs

    Nov 28, 2022 | Posted by Industry Expert | Financial and RCM |

    By David Burda, News Editor & Columnist, 4sight Health
    Twitter: @davidrburda
    Twitter: @4sighthealth_

    Sometimes little studies say a lot about how the healthcare system works in the U.S. and why we need a customer revolution in healthcare.

    A great example is a recent two-page research letter in JAMA Internal Medicine. Five researchers from Cartesian Therapeutics and the University of California at San Francisco wanted to know if there was any connection between the prices of oncology drugs approved by the FDA between 2015 and 2020 and the efficacy, or effectiveness, of those drugs in treating cancer patients.

    Their assumption, my assumption and probably your assumption is, more effective cancer drugs would cost more than less effective cancer drugs. No different than better house paint that covers in one coat costing more than cheaper house paint that rarely covers in two coats.

    As it turns out, oncology drugs are less like house paint and more like the kitchen gadgets that they test on America’s Test Kitchen. There’s little connection between effectiveness and cost, and often the less expensive drugs — and gadgets — work the best.

    Here’s how the researchers came up with that conclusion. They compared the efficacy and the median annual treatment cost of 224 oncology drugs approved by the FDA over the five-year study period. They defined efficacy in three ways:

    • Overall survival rate, or OS
    • Progression-free survival, or PFS
    • Overall response rate, or ORR

    (If you have cancer, OS is the one you want. Staying alive is the best outcome.)

    Overall, the median annual cost of the drugs was $196,000 for a yearly course of treatment. But that cost varied by the level of efficacy:

    • $185,000 for OS
    • $203,000 for PFS
    • $239,000 for ORR

    “In value-based pricing, drugs that are associated with greater improvements to the same endpoint or more improved objective endpoints would be expected to cost more,” the researchers said. “The results of this analysis suggest the opposite: oncology drugs approved based on OS improvement had the lowest median annual cost of the 3 endpoints.”

    In English, the best drugs were the cheapest. Just like when they tested oven mitts on America’s Test Kitchen.

    Why?

    “This suggests that cancer drugs are priced based predominantly on what the market will bear,” the researchers said.

    No translation needed there.

    Drug companies will charge as much as they can for an oncology drug regardless of how well it works for cancer patients. I’m sure that’s largely because desperate cancer patients and/or their families will pay anything for a chance to stay alive. How much would a man dying of thirst pay for a bottle of water?

    The question becomes, whose job is it to align efficacy and price or, in a word, value, for scared cancer patients?

    The only other people left at this party are the provider and the payer. Which one will step up to be the advocate for oncology drug value for the patient? Providers who turn a profit on the cancer drugs they prescribe for patients or payers who take kickbacks, oh, excuse me, rebates, for putting cancer drugs in the approved drug formularies?

    Thanks for reading.

    This article was originally published on 4sight Health and is republished here with permission.

    Tags: 4sight Healthcancer careDavid Burdapatient outcomes

    Radio for the Healthcare Industry

    No HTML5 audio playback capabilities for this browser. Use Chrome Browser!

    Categories

    Get Our News Digest


    Thank you!

    You have successfully joined our subscriber list.

    .

    Upcoming Events

    May 28
    May 28 - May 29

    DoD/VA & Government Health IT Summit

    Washington
    May 28
    7:30 am - 5:00 pm EDT

    21st Annual UCLA Nursing Science and Innovation Conference

    Los Angeles
    Jun 5
    June 5 - June 6

    Inaugural Virtual Reality in Sports Medicine & Exercise Science

    Sarasota
    View Calendar

    About HealthcareNOWRadio.com

    HealthcareNOWradio.com is an Internet radio station operated and produced as part of Answers Media Network. The station offers interviews, and commentary from industry leaders in healthcare and health information technology, as well as originally produced programming hosted by industry leaders. Listen on any device 24/7. You can also subscribe to get notification when a new show airs.

    Sign Up for Our e-News Digest

    Get notified when a new show airs or when your favorites are available as podcasts. Sign up here

    Connect with Us

    Request a Media Kit

    Contact Us

    Book a Guest

    Visit Health IT Answers

    ©2025 Answers Media Company, LLC

    • Our Privacy Policy
    • Our Guests and Recording Policy
    Prev Next

    Notifications